2011 - TID Conference


DONOR-DERIVED INFECTIONS

1.1 - DTAC and the American Experience with Donor Derived Infections

Presenter: Emily, Blumberg, Philadelphia, United States
Authors: Emily Blumberg


In 2005, the Disease Transmission Advisory Group was started by the OPTN/UNOS to assess reports of potential risk for transmission of infection and malignancy from donor to recipient of solid organ transplant. Since that time, the group has become an established Advisory Committee of the OPTN/UNOS (the organization charged with oversight of transplantation in the United States). The committee is a multidisciplinary committee with diverse membership, including Infectious Diseases physicians, Surgeons, Nephrologists, Oncologists, Pathologists, Transplant Nursing, Laboratory Directors, Organ Procurement Organization representation, government representatives, and UNOS staff. Last year 157 cases were investigated, including 116 related to infections and 42 reports related to malignancy. These resulted in 37 documented proven or probable transmission events. Of the infections, although bacteria were most commonly reported, protozoa/parasites and fungi had the most proven transmissions, perhaps reflecting more efficient transfer of pathogens. Renal cell carcinomas were the most common malignancy reports; but there were more documented transmission events with pulmonary malignancies. This presentation will highlight the experiences of DTAC during its first 6 years and review the U.S. response to disease transmission events.

You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi